herp
simplex
viru
hsv
human
pathogen
infect
epitheli
cell
cutan
lesion
caus
viru
spread
nervou
system
creat
sever
complic
fusion
host
membran
viral
envelop
mandatori
mediat
group
glycoprotein
conserv
herpesvirida
subfamili
glycoprotein
b
gb
h
gh
l
gl
gd
investig
inhibitori
activ
mediat
synthet
overlap
peptid
span
entir
ectodomain
gh
gl
glycoprotein
perform
brute
analysi
complet
ghgl
heterodim
order
explor
inhibitori
activ
peptid
model
glycoprotein
infect
twentyfour
gh
peptid
concentr
reach
inhibit
cutoff
interestingli
mainli
locat
gh
carboxytermin
domain
none
gl
peptid
clear
inhibit
effect
peptid
toxic
observ
lactat
dehydrogenas
assay
concentr
use
experiment
condit
therapi
base
acyclovir
treatment
resist
strain
emerg
scenario
innov
approach
treatment
necessari
data
support
direct
involv
describ
domain
process
viru
penetr
therefor
result
relev
potenti
develop
novel
therapeut
compound
prevent
infect
herp
simplex
virus
hsv
human
pathogen
infect
epitheli
cell
dsdna
virus
divid
three
subfamili
alfaherpesvirina
betaherpesvirina
gamma
herpesvirina
alfaherpesvirina
group
togeth
rel
fast
replic
cell
cycl
host
rang
abil
gener
latenc
sensit
ganglial
nerv
among
subfamili
import
speci
human
infect
repres
varicellazost
viru
common
hsv
treatment
base
acyclovir
valacyclovir
farmcyclovir
resist
strain
emerg
therefor
new
strategi
need
deal
infect
therapeut
peptid
becom
attract
tool
drug
discoveri
best
character
therapeut
antivir
peptid
inhibitor
enfuvirtid
fusion
inhibitor
mimic
ctermin
repeat
coil
region
human
immunodefici
viru
hiv
fusion
protein
specif
function
domain
protein
involv
mechan
cell
penetr
number
virus
found
abl
inhibit
infect
infect
initi
bind
glycoprotein
c
gc
cell
surfac
heparan
sulfat
gb
protein
gb
also
bind
heparan
sulfat
proteoglycan
bind
less
effici
follow
attach
gd
bind
one
number
coreceptor
host
cell
membran
includ
herpesviru
entri
mediat
nectin
nectin
heparan
sulfat
result
conform
chang
gd
conform
chang
gd
believ
trigger
format
fusion
complex
enabl
fusion
ensu
coexpress
gd
gb
ghgl
heterodim
cell
result
cellcel
fusion
indic
four
protein
constitut
minim
fusion
apparatu
although
entri
pathway
envelop
virus
share
similar
pattern
system
molecular
detail
gather
reli
singl
fusion
protein
singular
use
gb
ghgl
core
fusion
machineri
ghgl
complex
gb
interact
respons
receptor
bind
gd
interact
requir
allow
fusion
occur
tridimension
structur
ghgl
show
ghgl
heterodim
resembl
known
viral
fusogen
may
support
differ
role
gh
includ
fusion
regul
interact
gb
broad
literatur
describ
gh
involv
entri
process
exampl
certain
mutat
transmembran
tm
region
cytoplasm
tail
affect
fusion
mutat
region
preced
tm
furthermor
peptid
match
number
region
gh
ectodomain
shown
interact
membran
propos
play
role
fusion
process
probabl
regul
gb
activ
andor
direct
membran
interact
fusion
site
hsvinfect
cell
matur
virion
gh
gl
alway
found
togeth
heterodim
stabl
complex
reli
one
anoth
proper
fold
posttransl
process
transport
cell
virion
surfac
gh
type
membran
glycoprotein
ectodomain
contain
seven
nglycosyl
site
eight
cystein
residu
form
least
two
disulphid
bond
cystein
residu
cystein
residu
gl
protein
signal
peptid
tm
region
crystal
structur
ghgl
complex
solv
show
overal
shape
boot
gh
divid
three
distinct
domain
ntermin
domain
bind
gl
ii
central
helic
domain
iii
ctermin
domain
ntermin
domain
locat
upper
part
ghgl
boot
consist
two
subdomain
connect
linker
residu
first
subdomain
residu
contain
form
sixstrand
mix
four
strand
come
gl
plu
three
short
helic
second
subdomain
residu
contain
sixstrand
antiparallel
interest
note
ntermin
domain
fold
core
diverg
sequenc
central
domain
residu
globular
mostli
helic
ctermin
domain
residu
locat
toe
end
boot
side
compos
fivestrand
lead
tm
region
central
ctermin
domain
conserv
probabl
fold
differ
gh
protein
similarli
ntermin
domain
gh
gl
stabl
core
gl
residu
adopt
regular
secondari
structur
includ
three
helic
two
peptidebas
strategi
recent
use
studi
herpesviru
glycoprotein
function
sever
laboratori
analys
synthet
peptid
homolog
region
gc
gb
gh
differ
herpesvirus
order
inhibit
infect
previous
shown
peptid
model
gh
domain
high
interfaci
hydrophob
abl
inhibit
hsv
infect
well
peptid
correspond
helic
domain
recent
sever
studi
analys
viral
glycoprotein
gener
peptidebas
approach
dissect
whole
glycoprotein
order
search
function
import
region
besid
predict
bioinformat
motif
mechan
underli
abil
synthet
peptid
inhibit
fusion
current
unclear
region
glycoprotein
expos
surfac
may
involv
interact
protein
may
becom
expos
surfac
conform
rearrang
probabl
take
place
fusion
process
could
perhap
explain
abil
correspond
synthet
peptid
inhibit
cell
fusion
date
peptid
molecul
outsid
wellknown
inhibitori
region
class
viral
fusion
protein
heptad
repeat
fusion
therefor
brute
forc
approach
identif
peptid
entri
inhibitor
may
help
dissect
glycoprotein
domain
present
studi
use
peptid
scan
inhibit
approach
identif
function
domain
andor
lead
compound
infect
inhibitor
gener
overlap
peptid
librari
complet
sequenc
gl
gh
ectodomain
peptid
screen
abil
inhibit
infect
vero
cell
concentr
peptid
prepar
standard
polyamin
solidphas
synthesi
use
multispecif
peptid
synthes
shimadzu
corpor
biotechnolog
instrument
depart
kyoto
japan
tga
resin
substitut
mmol
g
use
solidphas
support
synthes
perform
scale
amino
acid
equiv
rel
resin
load
coupl
accord
tbtuhobtdiea
method
equiv
fmocamino
acid
equiv
tbtu
equiv
hobt
hobt
dmf
equiv
diea
diea
dmf
fmoc
protect
group
remov
piperidin
dmf
vv
peptid
fulli
deprotect
cleav
resin
tfa
solut
tfa
thioanisol
ethandithiol
anisol
scaveng
crude
peptid
precipit
icecold
ethyl
ether
filter
redissolv
water
lyophil
crude
peptid
purifi
homogen
prepar
reversephas
highpressur
liquid
chromatographi
water
delta
prep
chromatograph
system
equip
uv
lambda
max
mod
detector
sampl
inject
jupit
phenomenex
column
mm
cm
elut
h
tfa
ch
tfa
b
solvent
mixtur
linear
gradient
b
min
flow
rate
ml
min
employ
collect
fraction
lyophil
dryness
analys
analyt
reversephas
highpressur
liquid
chromatographi
shimadzu
equip
diod
array
detector
use
phenomenex
analyt
column
mm
linear
gradient
b
min
flow
rate
ml
min
use
ident
purifi
peptid
confirm
maldi
spectrometri
purifi
peptid
obtain
high
yield
african
green
monkey
kidney
cell
vero
atcc
grown
dulbecco
modifi
eagl
medium
dmem
supplement
fetal
bovin
serum
strain
carri
lacz
gene
driven
cmv
promot
express
propag
vero
cell
monolay
peptid
dissolv
dmem
without
serum
use
final
concentr
experi
conduct
parallel
scrambl
peptid
nopeptid
control
assess
effect
peptid
inhibit
hsv
infect
cotreat
assay
perform
triplic
statist
analysi
carri
via
ttest
pvalu
cell
incub
peptid
presenc
serial
dilut
viral
inoculum
min
inactiv
nonpenetr
virus
citrat
buffer
ph
cell
monolay
incub
h
dmem
supplement
carboxymethylcellulos
final
monolay
fix
stain
xgal
plaqu
number
score
experi
perform
triplic
percentag
inhibit
calcul
respect
nopeptid
control
experi
ic
ic
valu
peptid
concentr
result
hsv
infect
reduct
cotreat
assay
respect
extrapol
via
graphpad
prism
softwar
result
sigmoid
doserespons
curv
peptid
cytotox
measur
lactat
dehydrogenas
ldh
assay
carri
accord
manufactur
instruct
use
cytotox
detect
kit
roch
diagnost
spa
milano
itali
releas
ldh
cytosol
cultur
marker
cell
death
increas
ldh
activ
supernat
relat
percentag
necrot
cell
vero
cell
cultur
plate
densiti
cellswel
h
follow
treatment
investig
concentr
peptid
h
maxim
ldh
releas
obtain
treatment
control
cell
solut
triton
sigma
chemic
compani
min
room
temperatur
one
hundr
microlitr
supernat
top
well
mix
prepar
detect
kit
reagent
incub
absorb
measur
nm
tecan
spectrophotomet
plate
experi
least
three
replic
well
examin
test
potenti
use
peptid
antivir
agent
identifi
function
import
region
membran
glycoprotein
two
peptid
librari
construct
sequenc
gh
gl
ectodomain
consid
differ
size
two
glycoprotein
studi
decid
prepar
librari
differ
overlap
length
librari
peptid
extend
residu
begin
tm
domain
gh
second
librari
peptid
residu
correspond
whole
sequenc
gl
first
gh
librari
made
peptid
overlap
residu
supplementari
tabl
latter
design
residu
overlap
supplementari
tabl
signal
peptid
exclud
analysi
detail
exclud
first
aa
gh
sequenc
includ
peptid
signal
aa
first
aa
gl
sequenc
librari
screen
peptid
inhibitori
activ
use
plaqu
reduct
assay
viru
cell
expos
peptid
prior
infect
peptid
remain
present
throughout
assay
peptid
efficaci
measur
plaqu
reduct
assay
describ
materi
method
criterion
consid
peptid
potenti
interest
inhibit
least
plaqu
format
concentr
figur
show
ghoverlap
peptid
antivir
activ
screen
peptid
ghlibrari
peptid
show
inhibit
activ
tabl
threshold
reach
gl
peptid
supplementari
tabl
viral
inhibit
activ
pvalu
figur
inhibitori
activ
gh
peptid
rel
activ
normal
report
inhibit
threshold
lane
fix
infect
activ
statist
analysi
carri
via
pvalu
interest
note
best
inhibitor
locat
domain
interact
gh
aa
gl
previou
work
use
physicochem
algorithm
wimleywhit
interfaci
hydrophob
scale
wwih
combin
structur
data
allow
us
predict
region
gh
potenti
involv
membran
interact
entri
fusion
process
found
possess
hsv
antivir
activ
dosedepend
inhibit
assay
present
studi
extend
studi
appli
gener
peptidebas
approach
scan
entir
gh
ectodomain
accompani
glycoprotein
gl
chosen
threshold
includ
categori
put
inhibitori
peptid
dictat
gener
high
concentr
need
exert
antivir
activ
hsvderiv
peptid
previou
work
shown
concentr
peptid
rang
need
inhibit
hsv
infect
nevertheless
result
obtain
prove
peptidebas
strategi
target
region
protein
predict
structur
motif
repres
valid
option
search
function
region
protein
fact
whole
protein
scan
confirm
region
interest
sever
domain
alreadi
found
poss
antivir
activ
base
structur
characterist
peptid
span
region
gh
partial
overlap
helic
peptid
previous
name
aa
abl
reduc
infect
consist
manner
albeit
high
concentr
peptid
overlap
peptid
found
abl
inhibit
hsv
entri
approxim
inhibit
hydropathi
analysi
base
hydrophobicityatinterfac
scale
propos
wimley
white
enabl
detect
two
domain
hsv
gh
abl
induc
rapid
membran
fusion
inhibit
viral
entri
shorter
peptid
correspond
nterminu
almost
complet
overlap
present
work
abl
inhibit
hsv
entri
even
effect
final
peptid
extrem
cterminu
gh
ectodomain
tm
helic
domain
start
aa
previous
individu
part
larger
pretm
domain
abil
inhibit
viru
infect
peptid
previous
name
exactli
correspond
peptid
present
studi
nevertheless
remain
peptid
newli
identifi
present
inhibitori
activ
set
threshold
peptid
found
exhibit
inhibitori
effect
plaqu
format
tabl
order
defin
chemic
well
conform
properti
could
repres
common
shareabl
characterist
activ
peptid
perform
bioinformat
analysi
base
pepcalc
wwwpepcalccom
pepfold
http
bioservrpb
univparisdiderotfr
databas
respect
figur
chemic
physic
properti
highlight
share
characterist
peptid
detail
report
figur
peptid
subdivid
isoelectr
point
group
acid
ph
neutral
ph
basic
ph
second
instanc
peptid
cluster
base
charg
ph
shown
figur
found
peptid
repres
specif
cluster
like
first
group
well
second
interestingli
new
inhibit
peptid
present
acid
basic
group
one
peptid
present
neutral
group
moreov
perform
primari
secondari
structur
analysi
inhibit
gh
peptid
figur
peptid
cluster
togeth
sequenc
homolog
point
view
figur
cluster
directli
associ
inhibit
activ
figur
instanc
cluster
percentag
viral
inhibit
close
cluster
secondari
structur
bioinformat
peptid
analysi
report
figur
observ
cluster
differ
distribut
helic
coil
structur
low
presenc
extend
region
present
compar
other
final
confirm
peptid
exert
toxic
effect
vero
cell
monolay
expos
rang
concentr
inhibitori
peptid
h
cell
viabil
assay
ldh
assay
statist
differ
observ
viabil
control
untreat
cell
cell
expos
peptid
data
shown
thu
none
peptid
exhibit
cytotox
effect
concentr
test
viral
peptid
entri
inhibitor
describ
far
intent
design
order
inhibit
viral
entri
compet
intermolecular
interact
use
amino
acid
specif
sequenc
mostli
deriv
viral
fusion
protein
howev
activ
without
specif
molecular
target
envisag
mani
entri
inhibitor
peptid
peptid
albeit
deriv
viral
surfac
protein
belong
wellknown
hr
domain
often
scatter
expos
region
surfac
protein
domain
may
becom
expos
follow
conform
modif
trigger
bind
virus
receptor
environment
chang
insid
endosom
current
understand
mechan
action
peptid
find
hallmark
propens
membran
bind
due
interfaci
hydrophob
amphipat
view
characterist
peptid
could
hamper
viru
entri
establish
direct
physic
interact
hydrophob
interfac
membran
fusion
protein
essenti
peptid
bind
membran
membran
protein
viru
particl
therebi
exert
steric
hinder
effect
earli
stage
viral
penetr
viral
bind
andor
membran
fusion
sometim
interfer
fusion
protein
modif
prematur
initi
fusion
protein
becom
unabl
promot
fusion
peptid
bound
viral
envelop
membran
studi
describ
altern
approach
identifi
function
import
region
gh
gl
show
first
time
inhibit
activ
unreport
peptid
deriv
gh
protein
approach
involv
synthesi
two
librari
overlap
peptid
encompass
entir
ectodomain
gh
gl
bruteforc
scan
approach
prove
interest
analys
protein
sever
virus
fact
potenti
antivir
peptid
hepat
c
viru
hcv
discov
screen
overlap
peptid
cover
entir
hcv
polyprotein
eleven
peptid
strong
antivir
activ
identifi
activ
inhibitori
peptid
call
show
signific
hydrophob
membran
bind
propens
suggest
directli
interact
hcv
viral
envelop
block
infect
treat
virus
prior
initi
entri
stage
interestingli
also
abl
inhibit
hiv
disrupt
integr
viral
envelop
follow
line
four
protein
consid
play
role
promot
hcv
entri
name
scaveng
receptor
claudin
occlud
analys
overlap
amino
acid
peptid
scan
strategi
peptid
two
deriv
claudin
show
potent
inhibitori
activ
hcv
infect
furthermor
hcv
also
recent
analys
screen
peptid
librari
cover
fulllength
amino
acid
sequenc
peptid
stem
domain
found
block
cell
entri
hcv
peseudoparticl
nanomolar
concentr
peptid
sure
potenti
interest
prove
effici
major
hcv
genotyp
anoth
studi
assess
activ
peptid
cover
entir
capsid
protein
enteroviru
import
human
pathogen
may
caus
sever
neurolog
complic
case
strategi
prove
also
usabl
search
potenti
peptid
inhibitor
nonenvelop
virus
discoveri
four
peptid
abl
inhibit
infect
studi
describ
overlap
peptid
librari
synthes
combinatori
approach
peptid
deriv
subunit
spike
glycoprotein
sever
acut
respiratori
syndrom
associ
coronaviru
sarscov
could
block
bind
cellular
receptor
thu
entri
target
cell
bai
et
al
use
phage
display
methodolog
identifi
peptid
name
inhibit
west
nile
viru
wnv
infect
possibl
bind
envelop
glycoprotein
e
protein
necessari
membran
fusion
modifi
version
name
show
strongli
increas
inhibitori
activ
wnv
micrometr
concentr
interestingli
enter
brain
cross
blood
brain
barrier
reduc
infect
mous
model
brain
infect
moreov
interest
studi
sparkl
observ
hiv
patient
coinfect
common
asymptomat
gb
viru
c
viru
relat
hcv
present
lower
hiv
viremia
suggest
analysi
overlap
peptid
protein
gb
viru
c
allow
identif
two
peptid
abl
inhibit
hiv
vitro
competit
bind
interfac
also
hsv
glycoprotein
analys
peptid
scan
strategi
librari
overlap
peptid
encompass
ectodomain
gb
synthes
test
hsv
infect
inhibit
seven
peptid
inhibit
infect
test
concentr
interestingli
mani
antivir
peptid
identifi
brute
forc
approach
overlap
mani
peptid
discov
analys
hydrophob
interfac
scale
exampl
hsv
gb
remark
peptid
least
activ
also
previous
describ
membraneinteract
sequenc
use
wwih
result
scan
entir
sequenc
gh
gl
confirm
wwih
power
mean
identifi
potenti
antivir
peptid
region
potenti
interest
remain
underscor
therefor
systemat
analysi
whole
sequenc
overlap
peptid
librari
add
detail
inform
region
involv
inhibit
fact
abl
detect
four
area
peptid
could
group
antivir
activ
identifi
region
overlap
peptid
alreadi
describ
discov
bioinformat
tool
therebi
strengthen
clear
relationship
function
physiochem
charact
peptid
particular
four
identifi
inhibitori
area
mainli
locat
region
glycoprotein
name
small
area
locat
region
domain
gh
mainli
character
bundl
helic
extend
region
gh
deriv
pseudorabi
viru
prv
synthaxin
like
bundl
slb
present
region
motif
prove
import
disrupt
lead
impair
replic
activ
viru
interestingli
one
inhibitori
peptid
locat
gh
correspond
region
surprisingli
detect
activ
inhibit
assay
test
gl
deriv
peptid
may
like
account
neglig
role
gl
membran
interact
nevertheless
also
domain
gh
mainli
devot
interact
gl
provid
inhibitori
peptid
subdomain
clamp
gl
like
tong
make
extens
contact
interact
highli
complementari
surfac
fact
two
protein
need
fold
correctli
gl
power
scaffold
protein
gh
inabl
gh
peptid
deriv
domain
function
inhibitor
infect
explain
fact
format
highli
stabl
complex
two
glycoprotein
happen
matur
egress
infect
cell
therefor
structur
alreadi
definit
heterodim
becom
express
matur
virion
envelop
disrupt
gh
gl
interact
like
happen
whole
domain
would
result
unfold
structur
absenc
gl
four
area
activ
peptid
depict
figur
fill
surfac
protein
shown
interest
note
inhibitori
area
mainli
occupi
region
gh
domain
expos
extern
surfac
protein
area
partial
buri
insid
partial
expos
outsid
therefor
observ
consist
minor
inhibitori
activ
peptid
belong
area
furthermor
inhibitori
area
preced
ctermin
tm
domain
gh
part
ctemin
ectodomain
mainli
compos
constitut
larg
patch
hydrophob
residu
abl
interact
cell
membran
fusion
process
modifi
curvatur
viral
envelop
membran
fusion
import
step
envelop
viru
entri
host
cell
present
studi
antivir
activ
deriv
peptid
provid
larg
set
data
obtain
overlap
peptid
cover
whole
ectodomain
gh
gl
peptid
may
use
probe
gh
activ
membran
fusion
major
use
could
direct
antivir
molecul
act
earli
stage
discov
peptid
use
microbicid
topic
administr
follow
analysi
appropri
modif
improv
viabil
effici
matter
fact
consid
molecular
weight
peptid
categor
midsiz
drug
nowaday
receiv
consider
attent
medicin
chemistri
